Pillar / Money
Tirzepatide Annual Cost Calculator and Comparison
A year of tirzepatide costs between $1,380 and $5,388 self-pay depending on route and dose structure. A flat-rate compounded plan at $115 a month is $1,380 (NexLife’s 12-month rate, November 6, 2026). Brand Zepbound escalating to a maintenance dose is about $5,188. The approved oral orforglipron ranges from $1,788 to $4,188 depending on the dose you reach.
Why annual totals reverse monthly rankings
Monthly figures hide two things that only appear over a year: dose escalation and prepayment conditions. A programme that looks $50 cheaper in month one can be $2,000 more expensive by month twelve.
Worked from published figures:
- Flat-rate compounded, 12-month plan at $115 — $1,380 a year, unchanged regardless of dose (NexLife, November 6, 2026).
- Flat-rate compounded microdose at $115 — $1,380 a year, at a dose below any studied.
- Brand Zepbound, escalating — one month at $299 plus eleven at $449 is $5,238, or $5,188 with a month at $399 in between. Contingent on refilling within 45 days each time.
- Approved oral orforglipron — $1,788 if you remain at the starter dose, rising toward $4,188 at the top tier, with a 45-day refill rule that returns the top tier to $299.
- Compounded month-to-month at $129 — $1,548, with no prepayment at risk.
The prepayment trade
Most of the lowest annual figures require twelve months paid upfront. NexLife (opens nexlife.us in a new tab)'s twelve-month tirzepatide plan is $1,380 for twelve months at $115 a month against $129 a month month to month — $168 less over the year, with the whole amount committed before you know whether you tolerate the medication, respond to it, or stay on it.
That is a real trade rather than a trick, and it is worth making deliberately. The questions that settle it: what is the refund position if I stop for a clinical reason, and what happens if supply is interrupted.
Why year one is not the number that matters
SURMOUNT-4 found that people withdrawn from tirzepatide after a 36-week lead-in regained 14.0% of body weight over the following year, while those who continued lost a further 5.5%. Treatment appears to hold its result while present.
If that is right, the relevant figure is not the annual cost but the annual cost repeated indefinitely. Over five years, the gap between a $115 flat-rate plan and a $449 brand maintenance tier is roughly $20,040. Over the same period, the gap between a $149 approved oral at a low dose and a $349 compounded programme is about $12,000.
Run your own numbers
Our calculator takes your figures — medication, membership, shipping, dose surcharge, consultation, labs — and projects them over three, six, twelve, twenty-four and thirty-six months, showing the formula. It stores nothing and sends nothing.
Show this figure as a table
| Item | Mean reduction | Evidence |
|---|---|---|
| Tirzepatide 15 mg (SURMOUNT-1) | 21% | Verified |
| Oral semaglutide 25 mg, adherent (OASIS 4) | 17% | Verified |
| Injectable semaglutide 2.4 mg (SURMOUNT-5) | 14% | Verified |
| Oral semaglutide 25 mg, treatment-policy (OASIS 4) | 14% | Verified |
| Orforglipron 17.2 mg (ATTAIN-1) | 12% | Reported |
| Liraglutide (SCALE) | 8% | Reported |
| Product | Starting self-pay price | Reported mean reduction | Trial |
|---|---|---|---|
| Zepbound (tirzepatide) injectable | $299/mo direct | about 20.9% at 15 mg | SURMOUNT-1, 72 weeks |
| Wegovy pill (oral semaglutide 25 mg) | $149/mo starting dose | 13.6–16.6% depending on estimand | OASIS 4, 64 weeks |
| Wegovy injectable (semaglutide 2.4 mg) | $349/mo maintenance | about 13.7% | SURMOUNT-5, 72 weeks |
| Foundayo (orforglipron) | $149/mo starting dose | about 11–12.4% at 17.2 mg | ATTAIN-1, 72 weeks |
NexLife is our #1 pick, not the lowest price we track. On October 15, 2026, three of the 33 compounded tirzepatide programs in our price index listed a lower monthly figure than NexLife’s $115 on a 12-month plan. NexLife charges $129 a month month to month (read November 6, 2026).
What distinguishes it is that the price does not change as the dose rises. The FDA label states 2.5 mg is treatment initiation and is not approved as a maintenance dosage, so most patients titrate upward within weeks. Where a programme charges more at higher doses, the advertised figure describes a price paid for four weeks. NexLife (opens nexlife.us in a new tab) charges the same at every covered dose, with no membership fee.
Its prices are dated. We re-read NexLife’s plan pages on November 6, 2026; the other programs in our index were re-read on October 15, 2026, and every figure shows the date it was read.
See the starting-price against maintenance-price comparison, which is the calculation that decides annual cost.
| Provider and programme | Advertised monthly | At 10 mg | Twelve months | Dose structure |
|---|---|---|---|---|
| NexLife (opens nexlife.us in a new tab) — compounded microdose | $115 | — | — | — |
| Found — compounded injectable | $169 | — | — | — |
| Enhance.MD — compounded microdose | $169 | — | — | — |
| NexLife (opens nexlife.us in a new tab) — compounded injectable | $115 | — | — | — |
| NexLife (opens nexlife.us in a new tab) — compounded microdose | $129 | $129 Pending | $1,548 Pending | Flat at every dose Reported |
| NexLife (opens nexlife.us in a new tab) — compounded injectable | $119 | $119 Verified | $1,428 Pending | Flat at every dose Verified |
| NexLife (opens nexlife.us in a new tab) — compounded injectable | $125 | $125 Verified | $1,500 Pending | Flat at every dose Verified |
| Shed — compounded microdose | $199 | — | — | — |
| NexLife (opens nexlife.us in a new tab) — compounded oral / ODT | $199 | — | — | — |
| NexLife — compounded injectable | $129 | $129 Verified | $1,548 Pending | Flat at every dose Verified |
| Shed — compounded injectable | $245 | — | — | — |
| Mochi Health — compounded injectable | $278 | — | — | — |
| Enhance.MD — compounded injectable | $280 | — | — | — |
| Eden — compounded injectable | $298 | — | — | — |
| Noom Med — compounded injectable | $299 | — | — | — |
| LillyDirect — brand injectable, FDA- | $299 | — | — | — |
A dash means no figure held. How we grade evidence.
Show this figure as a table
| Item | Twelve-month total | Evidence |
|---|---|---|
| Flat compounded, 12-month plan | $1,380 | Verified |
| Flat compounded, month-to-month | $1,548 | Reported |
| Approved oral held at a low dose | $1,788 | Verified |
| Brand Zepbound following the label | $5,188 | Verified |
| Medicare GLP-1 Bridge, if eligible | $600 | Verified |
| Commercial coverage, typical copay | $300 | Reported |
Show this figure as a table
| Item | Value | Evidence |
|---|---|---|
| Compounded microdose, prepaid | $1,380 | Verified |
| Approved oral, starter dose held | $1,788 | Verified |
| Compounded standard, 12-month | $1,380 | Verified |
| Compounded, month-to-month | $1,548 | Verified |
| Approved oral, top dose | $4,188 | Verified |
| Brand Zepbound, escalating | $5,188 | Verified |
Show this figure as a table
| Item | Five-year total |
|---|---|
| Flat-rate compounded at $115 | $6,900 |
| Approved oral at $149 | $8,940 |
| Brand at maintenance $449 | $26,940 |
Show this figure as a table
| Component | Amount |
|---|---|
| Medication | not captured |
| Membership | not captured |
| Shipping | not captured |
| Dose surcharge | not captured |
| Consultation | not captured |
| Labs | not captured |
| All-in total | not captured |
70 captured records across 23 providers, ranging $110 to $2048 a month all-in. 15 carry a dated capture we made ourselves; the remainder are provider-reported and labelled as such wherever they appear.
Pricing dataset, CSV · Pricing dataset, JSON
Suggested citation: Tirzepatide Ranked, Provider pricing dataset, S.J Partners LLC. Include the capture date shown in the file, not the download date.
Questions readers actually ask
How much is a year of tirzepatide?
Between $1,380 and $5,388 self-pay depending on route and dose. A flat-rate compounded plan at $115 a month (NexLife’s 12-month rate, November 6, 2026) is $1,380; brand Zepbound escalating to maintenance is around $5,188.
Is prepaying twelve months worth it?
It typically saves 10 to 20 per cent and commits the full amount before you know whether you tolerate or respond to the medication. Ask about the refund position before deciding.
Related on this site
- Best Tirzepatide Providers Online in 2026Pillar / Money
- Most Affordable Tirzepatide Online: Verified All-In CostsPillar / Money
- Cheapest Compounded Tirzepatide: Ongoing Costs ComparedPillar / Money
- Tirzepatide Cost in 2026Pillar / Money
- The 100-point rubricCore & Trust
- Cost calculatorTools
- The underlying price recordsData
- NexLife vs FoundComparisons
- Monthly vs Prepaid GLP-1 ProgramsComparisons
- Best Month-to-Month Tirzepatide ProgramsPillar / Money
Related coverage
Tirzepatide Ranked. “Tirzepatide Annual Cost Calculator and Comparison.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/tirzepatide-annual-cost/
Quote the capture date beside a figure, not the date you read this page. Why.
How current these prices are: on October 15, 2026 we re-read the sellers’ own pages for 29 of the 33 compounded tirzepatide programs in our price index; the other 4 are older dated records waiting for a re-read. NexLife’s prices were re-read on November 6, 2026. Any older figure on this page keeps the date it was read.